debrisoquin has been researched along with Neuroses in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertilsson, L | 1 |
Dahl, ML | 1 |
Sjöqvist, F | 1 |
Aberg-Wistedt, A | 1 |
Humble, M | 1 |
Johansson, I | 1 |
Lundqvist, E | 1 |
Ingelman-Sundberg, M | 1 |
1 other study available for debrisoquin and Neuroses
Article | Year |
---|---|
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine.
Topics: Debrisoquin; Female; Humans; Hydroxylation; Metabolic Diseases; Neurotic Disorders; Polymorphism, Re | 1993 |